S&P 500 Futures
(-0.05%) 5 329.00 points
Dow Jones Futures
(-0.03%) 39 932 points
Nasdaq Futures
(-0.18%) 18 730 points
Oil
(-1.98%) $78.22
Gas
(-2.07%) $2.69
Gold
(-0.27%) $2 432.00
Silver
(-1.21%) $32.04
Platinum
(-0.12%) $1 062.40
USD/EUR
(0.05%) $0.921
USD/NOK
(-0.23%) $10.67
USD/GBP
(-0.02%) $0.787
USD/RUB
(-0.16%) $90.54

Realaus laiko atnaujinimai Regencell Bioscience [RGC]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta20 geg. 2024 @ 23:00

0.80% $ 5.06

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder...

Stats
Šios dienos apimtis 2 250.00
Vidutinė apimtis 4 520.00
Rinkos kapitalizacija 65.85M
EPS $0 ( 2024-01-26 )
Last Dividend $0.220 ( 2018-02-15 )
Next Dividend $0 ( N/A )
P/E -11.24
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2018-02-28 Anschutz Philip F Sell 12 440 000 CLASS A COMMON STOCK
2018-02-28 Anschutz Philip F Sell 23 708 639 CLASS B COMMON STOCK
2018-02-28 Campbell Michael L Sell 703 660 Class A Common Stock
2018-02-28 Yemenidjian Alex Sell 21 880 Class A Common Stock
2018-02-28 Tyrrell Jack Sell 136 684 Class A Common Stock
INSIDER POWER
0.00
Last 97 transactions
Buy: 583 544 | Sell: 71 137 085

Regencell Bioscience Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
QNRX0.939
RGF0.934
TCPC0.932
ACAD0.928
BNRG0.926
AGRX0.924
CNXC0.922
BCAN0.922
RRGB0.919
IRDM0.916
10 Labiausiai neigiamai susiję koreliacijos
ROAD-0.958
PVAL-0.947
EQRR-0.944
IUS-0.941
DVLU-0.939
RNA-0.937
MNMD-0.936
CPRT-0.935
ALLT-0.935
AIRG-0.934

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Regencell Bioscience Finansinės ataskaitos

Annual 2023
Pajamos: $0
Bruto pelnas: $-769 687 (0.00 %)
EPS: $-0.450
FY 2023
Pajamos: $0
Bruto pelnas: $-769 687 (0.00 %)
EPS: $-0.450
FY 2022
Pajamos: $0
Bruto pelnas: $-604 397 (0.00 %)
EPS: $-0.570
FY 2021
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-0.107

Financial Reports:

No articles found.

Regencell Bioscience Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Regencell Bioscience Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.180 2009-06-02
Last Dividend $0.220 2018-02-15
Next Dividend $0 N/A
Payout Date 2018-02-26
Next Payout Date N/A
# dividends 36 --
Total Paid Out $7.52 --
Avg. Dividend % Per Year 0.00% --
Score 1.86 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.13 Bad
Dividend Score
1.86
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
OXLC Dividend Diamond 2023-12-14 Monthly 14 10.00% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
OXSQ Dividend Royal 2023-12-14 Monthly 21 9.10% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
HRZN Dividend Royal 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-0.4651.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.4551.500-6.17-9.25[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM19.150.80010.008.00[1 - 3]
quickRatioTTM19.150.80010.008.00[0.8 - 2.5]
cashRatioTTM2.581.50010.0010.00[0.2 - 2]
debtRatioTTM0.0367-1.5009.39-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.1182.009.9610.00[0 - 30]
freeCashFlowPerShareTTM0.1182.009.9410.00[0 - 20]
debtEquityRatioTTM0.0385-1.5009.85-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM3.321.00010.0010.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.66

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-11.211.000-1.2340[1 - 100]
returnOnEquityTTM-0.4552.50-3.96-9.25[0.1 - 1.5]
freeCashFlowPerShareTTM0.1182.009.9610.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.1182.009.9610.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.2541.500-5.030[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-0.119

Regencell Bioscience Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Regencell Bioscience

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.